PT Ikapharmindo Putramas Tbk Stock

IKPM

ID1000199409

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 2026-06-22			5-day change	1st Jan Change
185.00 ^IDR	-2.63%		+2.21%	-17.41%

04-24	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-16	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Full Year Ended December 31, 2025	CI

on all subscriptions*

Exceptional extension!

Enjoy this offer

* See conditions under "Our services"

Valuation: PT Ikapharmindo Putramas Tbk

Market Cap	312B 17.48M 15.28M 14.13M 13.19M 24.76M 1.65B 24.94M 168M 65.33M 812M 65.64M 64.22M 2.82B	P/E 2024	82x	P/E 2025	-13.1x
Enterprise Value	436B 24.43M 21.35M 19.75M 18.43M 34.6M 2.31B 34.86M 235M 91.31M 1.14B 91.73M 89.74M 3.94B	EV / Sales 2024	1.35x	EV / Sales 2025	1.38x
Free-Float	20%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: PT Ikapharmindo Putramas Tbk

Timeframe

Style

Dynamic Chart

Latest news : PT Ikapharmindo Putramas Tbk

04-24	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-16	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25-10-28	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-07-28	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-05-02	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-26	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-28	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-07-29	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-05-17	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-29	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-11-06	PT Ikapharmindo Putramas Tbk has completed an IPO in the amount of IDR 55.593863 billion.	CI

More news

Managers and Directors: PT Ikapharmindo Putramas Tbk

Manager	Title	Age	Since
Kartono Gunawa CEO	Chief Executive Officer	-	-
Handri Sutanto AUD	Comptroller/Controller/Auditor	-	2013-07-31
Eliza Arlena Winata PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Maudy Ratna Winata CHM	Chairman	-	-
Titianus Winata BRD	Director/Board Member	-	-
Susanto Lam BRD	Director/Board Member	-	-

More insiders

PT Ikapharmindo Putramas Tbk is an Indonesia-based company. The Company is engaged in the marketing of pharmaceutical products and consumer health products located in Jakarta, Indonesia. The Company operates through two segments: Non Pharma, Pharma, and Contract manufacturing. The Company is focused on a diverse portfolio for the Indonesian market, with brands in the pharmaceutical product categories of prescription medicines, over the counter (OTC), nutraceuticals, professional hair care products and baby products. Its prescription pharmaceuticals include neurology, dermatology, gastroenterology, and cardiology. Its consumer division products consist of professional and retail haircare products, and also Baby HUKI, which consists of baby bottles and pacifiers, and other baby feeding equipment.

Employees

1,031

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-06-22	185.00 Rp	-2.63%	22,000
26-06-19	190.00 Rp	+1.60%	8,300
26-06-18	187.00 Rp	+5.06%	193,100
26-06-17	178.00 Rp	-0.56%	27,900

End-of-day quote INDONESIA S.E.

More quotes

Income Statement and Estimates

More financial data

Stock Market
Stocks
IKPM Stock

-40%: Exceptional extension

SEIZE THE OFFER!

1 day	-2.63%
1 week	+3.35%
1 month	-0.54%
3 months	-9.31%
6 months	-16.67%
Current year	-17.41%

1 week	173	195
1 month	167	197
Current year	167	340
1 year	167	340
3 years	164	340
5 years	164	340
10 years	164	340

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PT IKAPHARMINDO PUTRAMAS TBK	-2.63%	+2.21%	-15.91%	-	17.98M
ELI LILLY AND COMPANY	+0.32%	-2.41%	+44.49%	+140.80%	980B
JOHNSON & JOHNSON	+1.27%	-1.85%	+54.41%	+39.65%	550B
ABBVIE INC.	+6.25%	+3.80%	+24.13%	+67.39%	382B
ROCHE HOLDING AG	+0.25%	-1.93%	+23.33%	+16.35%	316B
ASTRAZENECA PLC	+0.42%	+0.68%	+27.89%	+14.57%	272B
NOVARTIS AG	+1.67%	+0.05%	+26.76%	+33.56%	268B
NOVO NORDISK A/S	+2.39%	+5.02%	-36.96%	-44.76%	199B
AMGEN INC.	+2.11%	-1.66%	+19.14%	+50.10%	182B
GILEAD SCIENCES, INC.	+0.90%	+0.46%	+15.09%	+59.86%	154B
Average	+1.30%	-1.11%	+18.24%	+41.95%	330.23B
Weighted average by Cap.	+1.53%	-2.66%	+31.28%	+64.51%

	2024	2025
Net sales	412B 23.11M 20.2M 18.68M 17.44M 32.74M 2.18B 32.98M 222M 86.38M 1.07B 86.78M 84.9M 3.73B	364B 20.39M 17.82M 16.48M 15.39M 28.88M 1.93B 29.09M 196M 76.21M 948M 76.57M 74.91M 3.29B
Net income	5.01B 281K 246K 227K 212K 398K 26.58M 401K 2.7M 1.05M 13.07M 1.06M 1.03M 45.41M	-28.78B -1.61M -1.41M -1.31M -1.22M -2.29M -153M -2.3M -15.51M -6.03M -75.02M -6.06M -5.93M -261M
Net Debt	147B 8.25M 7.21M 6.67M 6.23M 11.69M 780M 11.78M 79.29M 30.85M 384M 30.99M 30.32M 1.33B	124B 6.95M 6.07M 5.62M 5.24M 9.84M 657M 9.92M 66.76M 25.97M 323M 26.1M 25.53M 1.12B

PT Ikapharmindo Putramas Tbk Stock

Stocks

IKPM

ID1000199409

Pharmaceuticals

Valuation: PT Ikapharmindo Putramas Tbk

Chart: PT Ikapharmindo Putramas Tbk

Latest news : PT Ikapharmindo Putramas Tbk

Quotes and Performance

Course Extremes

Managers and Directors: PT Ikapharmindo Putramas Tbk

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates